Rare diseases
Investigational molecules
Locations
Ul. Spartanska 1, 02-637 Warsaw, Poland
Centrum Wsparcia Badań Klinicznych - CWBK (Clinical Trials Support Center) of the National Institute of Geriatrics, Rheumatology and Rehabilitation (NIGRiR) is a site conducting clinical trials in fields such as: rheumatology, immunology, neurology, cardiology, orthopedics, rehabilitation, pulmonology, and dermatology. In our modern center, clinical trials are conducted at the highest standard and with maximum comfort for patients.
CWBK, as a highly specialized unit, conducts clinical trials for patients from all over Poland, with particular attention to those who present diagnostic and therapeutic challenges, for whom participation in clinical trials may be the only chance to improve health, slow disease progression, or achieve remission.
The mission of CWBK’s experienced medical teams – doctors and nurses – is to ensure patients have access to modern forms of treatment, improving their health and quality of life, while maintaining the highest global standards of safety and respect for patient rights. The medical staff at CWBK is supported by a team of qualified administrative professionals experienced in managing medical and laboratory documentation in accordance with Good Clinical Practice (GCP) guidelines.
CWBK is actively involved in scientific and clinical initiatives with national and international research communities, paving the way for new projects, diagnostic methods, and future treatment solutions – namely, personalized medicine. The opportunity for these patients to participate in clinical trials not only opens access to drugs and therapies not financed by the National Health Fund (NFZ) but also reduces the cost of accessing and delivering treatment.
Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher in Warsaw, Poland specialises in clinical trials of conditions such as Sjogren's syndrome, Systemic lupus erythematosus, Psoriatic arthropathy, Axial spondyloarthritis, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in interstitial lung disease associated with systemic connective tissue diseases and hypersensitivity. The focus is on evaluating the efficacy of novel therapies like pirfenidone and nintedanib, aiming to improve patient outcomes and quality of life.
Through rigorous clinical trials, the center is advancing the understanding of these complex conditions, contributing to the development of more effective treatment protocols.
Specializing in Systemic Lupus Erythematosus, the center conducts extensive research to assess the safety and efficacy of innovative treatments like ESK-001 and deucravacitinib. These studies aim to enhance disease management and patient care.
The center's work is pivotal in developing new therapeutic strategies that address the diverse manifestations of SLE.
Research at the center includes a focus on psoriatic arthritis and axial spondyloarthritis, with studies on treatments like secukinumab and filgotinib. These efforts aim to improve long-term safety and efficacy in managing these chronic conditions.
By exploring new treatment avenues, the center is enhancing therapeutic options for patients with these debilitating diseases.
The center is pioneering research in knee osteoarthritis, focusing on the regenerative potential of treatments like RHH646. This research aims to provide innovative solutions for cartilage repair and pain management.
These studies are crucial in developing therapies that can significantly improve the quality of life for osteoarthritis patients.
Focusing on polymyalgia rheumatica, the center evaluates the efficacy of secukinumab in combination with glucocorticoid taper regimens. This research is vital for advancing treatment strategies for patients experiencing relapses.
The center's work is instrumental in refining therapeutic approaches to achieve better patient outcomes.
In the field of atrial fibrillation, the center is investigating the efficacy of abelacimab in reducing the risk of ischemic stroke. This research is crucial for patients unsuitable for traditional oral anticoagulation therapy.
Through these studies, the center is contributing to safer and more effective management of atrial fibrillation.
The center is advancing research in dermatomyositis and polymyositis, focusing on treatments like enpatoran and brepocitinib. These studies aim to improve muscle function and reduce disease activity.
By exploring new therapeutic options, the center is enhancing care for patients with these inflammatory myopathies.
Research at the center includes a focus on IgG4-related disease, with studies on the effects of obexelimab. This research is essential for understanding and managing disease flares effectively.
The center's work is pivotal in developing targeted therapies for this complex condition.
The center is at the forefront of research in gout and hyperuricemia, evaluating the efficacy of tigulixostat compared to allopurinol. This research aims to optimize uric acid management and improve patient outcomes.
Through these studies, the center is enhancing therapeutic strategies for managing gout effectively.
Specializing in Sjögren's syndrome, the center conducts research on treatments like deucravacitinib and efgartigimod. These studies focus on improving disease activity and long-term safety.
The center's work is crucial in developing effective management strategies for this autoimmune condition.
Research at the center includes a focus on giant cell arteritis, comparing the efficacy of etanercept and methotrexate. This research is vital for achieving steroid-free remission in patients.
Through these studies, the center is enhancing therapeutic options for managing giant cell arteritis.
The center is pioneering research in androgenetic alopecia, focusing on the efficacy and safety of Clascoterone solution. This research aims to provide innovative solutions for hair loss management.
These studies are crucial in developing therapies that can significantly improve the quality of life for patients with hair loss.
Clinical trials currently enrolling participants at this site.
PolandPolandPolandPolandPolandPolandPolandPolandPolandPolandPolandPolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
